Learn More about Lumida ETF
Powered by LumidaWealth.com
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
No Result
View All Result
  • Lumida Wealth
  • Lumida Ledger
  • LUMIDA ETF
  • About Us
Home News Markets

Cadillac’s Iconic Escalade Goes Electric With the Launch of the $127,700 Escalade IQ

by Team Lumida
April 14, 2025
in Markets
Reading Time: 4 mins read
A A
0
silver and diamond ring on white table

Photo by Endri Killo on Unsplash

Share on TelegramShare on TwitterShare on FacebookShare on LinkedinShare on Whatsapp

Key Takeaways:

Powered by lumidawealth.com

  • Cadillac has unveiled the all-electric Escalade IQ, priced at $127,700, marking its first fully electric version of the bestselling luxury SUV.
  • The Escalade IQ boasts a 465-mile range, 750 horsepower, and a luxurious interior with features like massaging rear seats, a panoramic glass roof, and a 19-speaker AKG sound system.
  • Despite the higher price tag—$40,000 more than the gas-powered version—Cadillac aims to position the Escalade IQ as a leader in the electric SUV market.
  • The launch comes at a time when EV sales are slowing, but Cadillac is betting on the Escalade’s brand power and appeal to affluent buyers to drive adoption.

What Happened?

Cadillac has introduced the Escalade IQ, an all-electric version of its flagship luxury SUV, as part of its push into the electric vehicle (EV) market. The Escalade IQ retains the opulence and size that have made the Escalade a cultural icon, while offering a driving range of 465 miles—outperforming competitors like the Kia EV9, Rivian R1S, and Volvo EX90.

The vehicle features a 55-inch curved dashboard screen, stowaway tray tables, massaging rear seats, and a front trunk for additional storage. It accelerates from 0 to 60 mph in just five seconds, despite its 9,000-pound weight, and offers a smooth, quiet ride.

However, the Escalade IQ’s size and advanced tech features, such as side cameras for city driving, may pose challenges for urban users. Cadillac is targeting families, suburban buyers, and professional drivers who value space, luxury, and long-range capabilities.


Why It Matters?

The Escalade IQ represents a bold move by Cadillac to electrify its most iconic model, even as other automakers delay or scale back EV production due to slowing sales. By leveraging the Escalade’s strong brand recognition and appeal to affluent buyers, Cadillac aims to carve out a niche in the high-end electric SUV market.

The vehicle’s 465-mile range addresses one of the biggest barriers to EV adoption—range anxiety—while its luxurious features and spacious design cater to families and livery drivers. However, the higher price point and reliance on public charging infrastructure may limit its appeal to a broader audience.

The Escalade IQ’s success will be a key test of whether Cadillac can maintain its dominance in the luxury SUV segment while transitioning to an electric future.


What’s Next?

Cadillac will monitor consumer response to the Escalade IQ as it rolls out this spring. The company is betting that affluent buyers will embrace the electric version of its flagship SUV, particularly in suburban and rural markets where charging infrastructure is less of a concern.

The broader EV market will also watch closely, as the Escalade IQ’s performance could influence other automakers’ strategies for electrifying large luxury vehicles. Cadillac’s ability to balance luxury, performance, and practicality will be critical in determining whether the Escalade IQ can replicate the success of its gas-powered predecessor.

Source
Previous Post

Is There a New U.S. Risk Premium? Rising Bond Yields and Falling Dollar Signal Global Concerns

Next Post

AI Stock-Analytics Chatbot BridgeWise Expands to Dubai as Regional Hub

Recommended For You

Mars to Invest $2 Billion in U.S. Manufacturing Over Next 18 Months

by Team Lumida
11 hours ago
Mars to Invest $2 Billion in U.S. Manufacturing Over Next 18 Months

Key Takeaways: Powered by lumidawealth.com New Investment: Mars plans to invest an additional $2 billion in its U.S. factories over the next 18 months, building on $6 billion invested...

Read more

Apple to Close Retail Store in China for the First Time Amid Changing Market Conditions

by Team Lumida
16 hours ago
apple logo on blue surface

Key Takeaways: Powered by lumidawealth.com First Store Closure in China: Apple will shut its Parkland Mall store in Dalian City on August 9, marking its first retail store closure...

Read more

Samsung Secures $16.5 Billion Tesla Chip Deal to Revive Foundry Business

by Team Lumida
2 days ago
blue coupe parked beside white wall

Key Takeaways: Powered by lumidawealth.com Massive Contract Win: Samsung Electronics secured a $16.5 billion semiconductor manufacturing deal with Tesla running through 2033, providing a major boost to its struggling...

Read more

LVMH in Talks to Sell Marc Jacobs Brand for Around $1 Billion

by Team Lumida
4 days ago
LVMH in Talks to Sell Marc Jacobs Brand for Around $1 Billion

Key Takeaways: Powered by lumidawealth.com Billion-Dollar Sale: LVMH is in discussions to sell the Marc Jacobs fashion brand for approximately $1 billion, marking another strategic divestiture by the luxury...

Read more

Morgan Stanley Becomes First U.S. Firm to Issue Panda Bond in China

by Team Lumida
5 days ago
Morgan Stanley Q2 2024 Earnings Summary

Key Takeaways: Powered by lumidawealth.com Historic First: Morgan Stanley has issued a 2 billion yuan $279 million) five-year panda bond, marking the first time a U.S. company has tapped...

Read more

T-Mobile Tops Rivals With Subscriber Gains, Raises Outlook

by Team Lumida
6 days ago
T-Mobile Tops Rivals With Subscriber Gains, Raises Outlook

Key Takeaways: Powered by lumidawealth.com Subscriber Growth Beats Expectations: T-Mobile added 830,000 net postpaid wireless phone connections in Q2 (up 7% YoY) and 454,000 net broadband connections (up 12%),...

Read more

Chinese Hackers Exploit Microsoft SharePoint Flaws, Breaching U.S. Nuclear Agency and Dozens More

by Team Lumida
7 days ago
China’s Bold Economic Moves: What You Need to Know Now

Key Takeaways: Powered by lumidawealth.com Widespread Breach: Chinese state-sponsored hackers exploited vulnerabilities in Microsoft SharePoint, breaching over 100 servers across 60 organizations—including the U.S. National Nuclear Security Administration, Education...

Read more

Goldman Sachs: Trump’s Tariffs to Lift Baseline Rate to 15%, Fueling Inflation and Slowing Growth

by Team Lumida
7 days ago
Goldman Predicts US Job Market Shift: Stands by Two Rate Cut Forecast

Key Takeaways: Powered by lumidawealth.com Tariff Hike Expected: Goldman Sachs forecasts the U.S. baseline “reciprocal” tariff rate will rise from 10% to 15%, with a 50% levy on copper...

Read more

Morgan Stanley Faces Expanded Scrutiny Over Client Vetting and Anti-Money-Laundering Controls

by Team Lumida
7 days ago
Morgan Stanley Faces Expanded Scrutiny Over Client Vetting and Anti-Money-Laundering Controls

Key Takeaways: Powered by lumidawealth.com Finra Probe Widens: Wall Street’s self-regulator, Finra, is investigating whether Morgan Stanley properly screened wealth-management and trading clients for money-laundering risks from October 2021...

Read more

AstraZeneca to Invest $50 Billion in U.S. Manufacturing and R&D by 2030 Amid Tariff Threats

by Team Lumida
1 week ago
AstraZeneca to Invest $50 Billion in U.S. Manufacturing and R&D by 2030 Amid Tariff Threats

Key Takeaways: Powered by lumidawealth.com Major U.S. Commitment: AstraZeneca will invest $50 billion in the U.S. by 2030*, including a new manufacturing center in Virginia focused on chronic disease...

Read more
Next Post
AI Stock-Analytics Chatbot BridgeWise Expands to Dubai as Regional Hub

AI Stock-Analytics Chatbot BridgeWise Expands to Dubai as Regional Hub

Mantra’s OM Token Crashes 90% Amid Allegations of Forced Liquidations and Market Manipulation

Mantra’s OM Token Crashes 90% Amid Allegations of Forced Liquidations and Market Manipulation

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related News

US Treasury Secretary Bessent: Terming Out US Debt Is “A Long Way Off”

G-7 Nations Back ‘Side-by-Side’ Tax Deal, Averting Global Tax War

June 29, 2025
CoreWeave Reports Fivefold Revenue Growth but Warns of Margin Pressure Amid Increased Investments

CoreWeave Reports Fivefold Revenue Growth but Warns of Margin Pressure Amid Increased Investments

May 15, 2025
$81 Billion Chip War: Can the US Overtake China?

$81 Billion Chip War: Can the US Overtake China?

May 24, 2024

Subscribe to Lumida Ledger

Browse by Category

  • Lifestyle
    • Family Office
    • Health and Longevity
    • Next Gen Wealth
    • Trust, Tax, and Estate
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Latest
    • Macro
    • Markets
    • Real Estate
  • Research
    • Trackers
  • Themes
    • Aging & Longevity
    • AI
    • Biotech
    • CRE
    • Cybersecurity
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
    • Software
Facebook Twitter Instagram Youtube TikTok LinkedIn
Lumida News

Premium insights to help you invest beyond the ordinary. Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser

CATEGORIES

  • Aging & Longevity
  • AI
  • Alt Assets
  • Biotech
  • CRE
  • Crypto
  • Cybersecurity
  • Digital Assets
  • Equities
  • Family Office
  • Health and Longevity
  • Latest
  • Legacy Brands
  • Lifestyle
  • Macro
  • Markets
  • News
  • Next Gen Wealth
  • Nuclear Renaissance
  • Private Credit
  • Real Estate
  • Software
  • Themes
  • Trackers
  • Trust, Tax, and Estate

BROWSE BY TAG

AI AI chips AI demand Amazon Apple Artificial Intelligence Banking Bitcoin China Commercial Real Estate CPI Crypto Donald Trump EARNINGS ELON MUSK ETF Ethereum Federal Reserve financial services generative AI Goldman Sachs Google India Inflation Interest Rates Investment Strategy Japan Jerome Powell JPMorgan Markets Meta Microsoft Nasdaq Nvidia OpenAI private equity S&P 500 SEC Semiconductor stock market Tech Stocks tesla Trump Wells Fargo Whale Watch

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018

No Result
View All Result
  • Home
  • Earnings
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018